drugset / Trial / NCT03504566

Rotation for Optimal Targeting of Albuminuria and Treatment Evaluation (ROTATE-2)

NCT03504566

RandomizedSingle-groupOpen-labelTreatment

Summary

This project is an intervention study where type 2 diabetic patients will rotate through 4 different albuminuria lowering drugs with the aim to 1) quantify the individual relationship between drug exposure and albumin lowering response of different albuminuria lowering drugs in type 1 and type 2 diabetics; and 2) to investigate the effect of the same drug intervention on the glycocalyx layer in blood vessels. The overall purpose of this study is to allow for future personalized treatment of diabetics with regards to treating kidney disease more effectively than current standardized strategies.

Timeline

Start
2017-11-15
Primary completion
2019-06-01
Completion
2019-06-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Empagliflozin Small molecule
Subject Linagliptin Small molecule
Subject Sulodexide Other / unclassified
Subject Telmisartan Other / unclassified